Speakers - Sachs Associates

CONTACTS
Dr Raúl Insa
Chief Executive Officer
Dra Nuria Gavaldá
R&R Manager
ADDRESS
Barcelona Science Park
Baldiri Reixac, 4
08028- Barcelona
Spain
TELEPHONE
+34 93 402 0150
+34 69 062 3263
FAX
+34 93 403 4510
EMAIL
insa@sombiotech.com
YEAR FOUNDED
2006
SOM Biotech
www.sombiotech.com
FINANCIAL SUMMARY
Sources of Financing
Founders: €109.000
FFFs: €261.000
VC firm: €100.000
Institutional: €500.000
Grants & loans:
Investment in R&D
€1.392.600
2010 €201.000
2011 €653.000
2012 (expected) €800.000
Funding capital required: €10.000.000
Funding application: To secure the two most advanced products to Phase IIa p.o.c. in humans.
Expected sales: > €60Mill in 2015
COMPANY PROFILE
SOM Biotech has developed a proprietary Drug Repurposing technology platform for discovery of new
therapeutic indications for given drugs, which we are offering to partners for expanding their drug pipeline.
During the last 34 months we have validated 41 new indications, with 18 positive hits (43%), of which 3 cover
clear medical need indications:
SOM0777 for the treatment of Glioma, already licensed to Argon Pharma and Draconis Pharma.
SOM0226 for the treatment of TTR-Amyloidosis. Orphan Disease. Phase II planned for 1Q 2013.
SOM0606 for the topical treatment of Psoriasis, in preclinical development. Phase II expected for 4Q 2013.
25 more repurposing programs per year are running to file the advanced company pipeline.
MANAGEMENT
Raúl Insa, MD, PhD, MBA., Chief Executive Officer
Ignasi Belda, PhD., Founder & Member of the Board
Ramon Morera, BS, MBA., Part-time Chief Financial Officer
Joaquim Trias, PhD., Advisor & Member of the Board
Núria Gavaldà, PhD., R&D Manager
Núria Reig, PhD., IP & Project Coordinator
Hermann Mucke, PhD., Member of the Board of Advisors
t back :: next u
WELCOME PHARMA LICENSING GROUPS
SPEAKERS
PRESENTING COMPANIES SUPPORTING ORGANISATIONS
ORGANISERS